{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:46:08Z","timestamp":1792457168850,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jgar.2023.05.006","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T15:59:55Z","timestamp":1684511995000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Prevalence of antibiotic resistance of Staphylococcus aureus in cystic fibrosis infection: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"36","author":[{"given":"Xuemei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyal","family":"Abbasi Tadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.05.006_bib0001","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: a disease with a new face","volume":"109","author":"De Boeck","year":"2020","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.jgar.2023.05.006_bib0002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fmicb.2021.617784","article-title":"How bacterial adaptation to cystic fibrosis environment shapes interactions between Pseudomonas aeruginosa and Staphylococcus aureus","volume":"12","author":"Camus","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2023.05.006_bib0003","article-title":"High-throughput functional analysis of CFTR and other apically localized channels in iPSC derived intestinal organoids","author":"Xia","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jgar.2023.05.006_bib0004","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/genes10030183","article-title":"Progression of cystic fibrosis lung disease from childhood to adulthood: neutrophils, neutrophil extracellular trap (NET) formation, and NET degradation","volume":"10","author":"Khan","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.jgar.2023.05.006_bib0005","first-page":"19","article-title":"Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology","author":"Rout-Pitt","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jgar.2023.05.006_bib0006","first-page":"1147","article-title":"Does biofilm formation have different pathways in Staphylococcus aureus?","volume":"22","author":"Shivaee","year":"2019","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.jgar.2023.05.006_bib0007","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/iub.2325","article-title":"Role of microRNAs in Staphylococcus aureus infection: potential biomarkers and mechanism","volume":"72","author":"Mirzaei","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jgar.2023.05.006_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajic.2020.05.031","article-title":"Staphylococcus aureus colonization increases the risk of bacteremia in hemodialysis patients: a molecular epidemiology approach with time-dependent analysis","volume":"49","author":"Vanegas","year":"2021","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2023.05.006_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.celrep.2019.12.001","article-title":"Hyaluronan degradation by cemip regulates host defense against Staphylococcus aureus skin infection","volume":"30","author":"Dokoshi","year":"2020","journal-title":"Cell Reports"},{"key":"10.1016\/j.jgar.2023.05.006_bib0010","first-page":"12","article-title":"Staphylococcus aureus pathogenicity in cystic fibrosis patients\u2014results from an observational prospective multicenter study concerning virulence genes, phylogeny, and gene plasticity","author":"Lange","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.jgar.2023.05.006_bib0011","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1039\/C9MD00044E","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype","volume":"10","author":"Craft","year":"2019","journal-title":"Med Chem Comm"},{"key":"10.1016\/j.jgar.2023.05.006_bib0012","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/ppul.24139","article-title":"Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis","volume":"53","author":"Akil","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jgar.2023.05.006_bib0013","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/jac\/dkn302","article-title":"High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation","volume":"62","author":"Molina","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.05.006_bib0014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcf.2007.07.010","article-title":"High prevalence of inducible clindamycin resistance among Staphylococcus aureus isolates from patients with cystic fibrosis","volume":"7","author":"Moore","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2023.05.006_bib0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10096-010-1000-5","article-title":"Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients","volume":"29","author":"Cafiso","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2023.05.006_bib0016","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1590\/S0037-86822010000400008","article-title":"High prevalence of methicillin-resistant Staphylococcus aureus with SCCmec type III in cystic fibrosis patients in southern, Brazil","volume":"43","author":"Reiter","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.jgar.2023.05.006_bib0017","first-page":"105","article-title":"Analysis of the frequency of isolation and drug resistance of microorganisms isolated from the airways of adult CF patients treated in the Institute of Tuberculosis and Lung Disease during 2008-2011","volume":"81","author":"Iwanska","year":"2013","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1016\/j.jgar.2023.05.006_bib0018","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jcf.2013.04.009","article-title":"Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients","volume":"12","author":"Vanderhelst","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2023.05.006_bib0019","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ppul.22815","article-title":"Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis","volume":"49","author":"Champion","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jgar.2023.05.006_bib0020","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1378\/chest.07-2437","article-title":"Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus","volume":"133","author":"Glikman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2023.05.006_bib0021","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2007.06.006","article-title":"Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis","volume":"7","author":"Valenza","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2023.05.006_bib0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcf.2011.06.005","article-title":"Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview","volume":"10","author":"Cocchi","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2023.05.006_bib0023","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ppul.21383","article-title":"Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis","volume":"46","author":"Leahy","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jgar.2023.05.006_bib0024","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/INF.0000000000000714","article-title":"Increased prevalence and resistance of important pathogens recovered from respiratory specimens of cystic fibrosis patients during a decade","volume":"34","author":"Raidt","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.jgar.2023.05.006_bib0025","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1128\/AAC.02067-15","article-title":"Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis","volume":"60","author":"De Dios Caballero","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jgar.2023.05.006_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/mdr.2016.0048","article-title":"Increasing incidence of multidrug resistance among cystic fibrosis respiratory bacterial isolates","volume":"23","author":"Rutter","year":"2017","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2023.05.006_bib0027","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/mdr.2017.0162","article-title":"Molecular epidemiology of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients from Argentina","volume":"24","author":"Pena Amaya","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2023.05.006_bib0028","article-title":"Activity of telavancin against staphylococcus aureus isolates, including those with decreased susceptibility to ceftaroline, from cystic fibrosis patients","volume":"27","author":"Roch","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.05.006_bib0029","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijmm.2018.02.003","article-title":"Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study","volume":"306","author":"Schwerdt","year":"2018","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.jgar.2023.05.006_bib0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.diagmicrobio.2017.11.012","article-title":"Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients","volume":"90","author":"Suwantarat","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2023.05.006_bib0031","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcf.2018.04.008","article-title":"Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: result of a Belgian national survey","volume":"18","author":"Dodemont","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2023.05.006_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213497","article-title":"Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: a randomized multicenter study","volume":"14","author":"Dolce","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2023.05.006_bib0033","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201810-1919OC","article-title":"Changing prevalence of lower airway infections in young children with cystic fibrosis","volume":"200","author":"Breuer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2023.05.006_bib0034","first-page":"36","article-title":"The most common causes of bacterial infections in children with cystic fibrosis","volume":"3","author":"Dramlic","year":"2021","journal-title":"Educ Res (IJMCER)"},{"key":"10.1016\/j.jgar.2023.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2021.03.018","article-title":"Imani Fooladi AA Effect of sub-lethal doses of nisin on Staphylococcus aureus toxin production and biofilm formation","volume":"197","author":"Shivaee","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.jgar.2023.05.006_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00735-20","article-title":"Genotypic and phenotypic diversity of Staphylococcus aureus isolates from cystic fibrosis patient lung infections and their interactions with Pseudomonas aeruginosa","volume":"11","author":"Bernardy","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.jgar.2023.05.006_bib0037","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.rmed.2015.01.013","article-title":"Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre","volume":"109","author":"Hall","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jgar.2023.05.006_bib0038","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jcf.2020.02.012","article-title":"Finding the relevance of antimicrobial stewardship for cystic fibrosis","volume":"19","author":"Cogen","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2023.05.006_bib0039","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CPM.0000000000000370","article-title":"Antibiotic use and stewardship in cystic fibrosis: a review for noncystic fibrosis providers","volume":"27","author":"Orsini","year":"2020","journal-title":"Clin Pulm Med"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T21:48:36Z","timestamp":1712699316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":39,"alternative-id":["S2213716523000826"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.05.006","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of antibiotic resistance of Staphylococcus aureus in cystic fibrosis infection: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}